Li Tianquan, a senior executive of yaozhi.com, and his party went to Chongqing Institute of drug control to give a lecture

Yesterday (June 2), Li Tianquan, the co-founder of yaozhi.com and the general manager of R & D center, and his party went to Chongqing Institute of food and drug inspection and testing (hereinafter referred to as "the Institute") to hold lectures on databases related to generic drug consistency evaluation and enterprise database knowledge After more than two hours of in-depth explanation and Q & A of medical big data, it has aroused strong response from R & D personnel The co-founder of yaozhi.com and general manager of R & D center explained the consistency evaluation of generic drugs on the spot The leaders and R & D personnel of the drug inspection institute listened attentively to the impact of the policies of the pharmaceutical industry on the R & D personnel's competing questions on the consistency evaluation The Chongqing drug Inspection Institute paid special attention to the issues related to the consistency evaluation of generic drugs In the busy schedule, the leaders of the hospital called together the staff of the medicine room, chemical medicine room, pharmacology room, biological products and other departments to attend the lecture, during which they had a heated discussion on how to find the standard products In view of this phenomenon, Li Tianquan made a detailed analysis and explanation on the thinking of generic drug consistency evaluation, answered all kinds of questions of field personnel, and explained the value of big data of pharmaceutical intelligence in generic drug consistency evaluation, such as real-time query of various policies and regulations, query of reference preparation, synthesis method and way, etc., which was favored by field researchers and affirmed the pharmaceutical intelligence Big data is a pioneer in the field of medical big data In addition, after a series of in-depth exchanges, the leaders of each department of the drug testing institute combined with their needs to provide many constructive opinions for the big data of drug intelligence In particular, the leaders of the traditional Chinese medicine department said that they are very optimistic about the big data of pharmaceutical intelligence It can save them a lot of time because of its comprehensive and authoritative information, convenient and quick retrieval She will always support our work and bridge the development of the enterprise.